Management Est News Today

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Fiscal 2021 First Quarter Results Helix" or the " Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced its fiscal 2021 first quarter results for the period ending October 31, 2020. OVERVIEW The Company reported a net loss and total comprehensive loss of $222,000 for the three-month period ended October 31, 2020...

Forward-Looking Statements and Risks and Uncertainties This news release contains forward-looking statements and information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities laws. Forward-looking statements are statements and information that are not historical facts but instead include financial projections and estimates, statements regarding plans, goals, objectives, intentions and expectations with respect to the Companys future business, oper...